作者:
Hoiseth,S.K. [1]
;
Murphy,E. [2]
;
Andrew,L. [3]
;
Vogel,U. [4]
;
Frosch,M. [5]
;
Hellenbrand,W. [6]
;
Abad,R. [7]
;
Vazquez,J.A. [8]
;
Borrow,R. [9]
;
Findlow,J. [10]
;
Taha,M.-K. ;
Deghmane,A.-E. ;
Caugant,D.A. ;
Kriz,P. ;
Musilek,M. ;
Mayer,L.W. ;
Wang,X. ;
MacNeil,J.R. ;
York,L. ;
Tan,C.Y. ;
Jansen,K.U. ;
Anderson,A.S.
作者单位:
National Institute of Public Health, Prague, Czech Republic
[1]
National Institute of Health, Carlos III, Madrid, Spain
[2]
Robert Koch Institute, Berlin, Germany
[3]
Centers for Disease Control and Prevention, Atlanta, GA, United States
[4]
Norwegian Institute of Public Health, Oslo, Norway
[5]
Pfizer Vaccine Research, 401 N. Middletown Rd., Pearl River, NY 10965, United States
[6]
Health Protection Agency, Manchester Royal Infirmary, Manchester, United Kingdom
[7]
Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany
[8]
Institut Pasteur, Paris, France
[9]
Pfizer, Collegeville, PA, United States
[10]
发布时间
2014-04-03